Drug intelligence / Profile preview

Savlon

Development stage
Unknown
Lead developer
Thornton & Ross
Modality
Small Molecules
Administration
Topical
01

Overview

Savlon is a widely available over-the-counter topical antiseptic cream containing the active ingredients cetrimide and chlorhexidine digluconate. It is primarily used for the treatment of minor skin injuries, burns, and abrasions to prevent infection. In the specific context of clinical research conducted by the Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia, Savlon was utilized as an active comparator in a Phase 2 cluster-randomized trial in rural Papua New Guinea. This study evaluated the efficacy of traditional plant-based antiseptics (such as *Ficus septica* and *Pterocarpus indicus* exudates) against Savlon for the healing of small infected cutaneous ulcers in children. Savlon exerts its therapeutic effect through broad-spectrum antibacterial activity; chlorhexidine disrupts microbial cell membranes, while cetrimide acts as a quaternary ammonium disinfectant that further destabilizes cell structures and denatures proteins.

Brand names
SavlonSavlon Antiseptic Cream
Other names
cetrimide + chlorhexidine digluconate
02

Targets

Microbial cell membrane phospholipid bilayer

Beyond the preview

Go deeper on Savlon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Savlon.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call